Speakers

Bernhard Kuster holds a chemistry degree from Cologne, a PhD in Biochemistry from Oxford and did his PostDoc at the EMBL in Heidelberg and the University of Southern Denmark. After seven years as Vice President Analytical Sciences and Informatics at Cellzome (now GSK), he became Full Professor of Proteomics at the TU Munich in 2007. He is also the Director of the Bavarian Biomolecular Mass Spectrometry Center, Co-Director of the Center for Infection Prevention, Spokesperson of the German national initiative on Mass Spectrometry in Systems Medicine and leads the Clinical Mass Spectrometry Center Munich project. Bernhard is a member of the German National Academy of Science, Leopoldina. 

Bernhard’s research focuses on proteomics and its application to chemical and cancer biology. He is interested in understanding how cancer drugs actually work and has received an ERC Advanced Grant in 2019 aiming to integrate proteomics into precision medicine. Bernhard has received several awards, including from the Human Proteome Organization for a first draft of the human proteome and his long-standing contributions to the field of chemical proteomics. Bernhard has co-founded two successful start-up companies that operate in the area of proteomics and artificial intelligence.